Case vignettes and other brain teasers of monoclonal gammopathies
1Department of Hematology, Mayo Clinic, Rochester, MN 55905, USA. gertm@mayo.edu
Abstract:
There are a number of rare monoclonal gammopathies that do not have a characteristic laboratory, imaging, or pathologic study. Recognition requires keeping the specific syndrome in mind. This article reviews 6 rare syndromes associated with monoclonal proteins and gives specific "pearls" so a clinician can be certain not to overlook these important disorders that easily can be misdiagnosed as MGUS, Waldenstrom, and multiple myeloma.
Insights
This review highlights six rare monoclonal gammopathies that often evade diagnosis. Recognizing these uncommon disorders is crucial to avoid misdiagnosis as more common conditions like MGUS or multiple myeloma.
Area of Science:
- Hematology
- Oncology
- Clinical Pathology
Background:
- Monoclonal gammopathies encompass a spectrum of plasma cell disorders.
- Diagnosis often relies on characteristic laboratory, imaging, or pathological findings.
- Rare monoclonal gammopathies may lack these typical diagnostic features.
Observation:
- Six specific rare syndromes associated with monoclonal proteins are reviewed.
- These disorders can be easily misdiagnosed as monoclonal gammopathy of undetermined significance (MGUS), Waldenstrom macroglobulinemia, or multiple myeloma.
- Clinical recognition requires maintaining awareness of these specific entities.
Findings:
- The article provides key diagnostic "pearls" for identifying these rare conditions.
- It emphasizes the importance of considering these syndromes in the differential diagnosis.
- Distinguishing these rare gammopathies from more common plasma cell neoplasms is essential.
Implications:
- Improved recognition of rare monoclonal gammopathies can lead to earlier and more accurate diagnoses.
- Timely diagnosis prevents misclassification and inappropriate treatment.
- Awareness of these "hidden" disorders enhances clinical management of monoclonal protein-associated conditions.
